Skip to Content

Labiana Pharmaceuticals, Spain, 2024

GMP Audit Report

Company
Labiana Pharmaceuticals

Product(s)
METROVIS ( API Metronidazol)

Country
Spain

Audit Year
2024

0.00 € 0.00 €
0.00 €